Healthy volunteers help test new Drug's absorption
NCT ID NCT06849791
First seen Nov 01, 2025 · Last updated May 16, 2026 · Updated 28 times
Summary
This early-stage study in 9 healthy adults aims to understand how the experimental drug ABBV-932 is absorbed and processed by the body, including whether food affects its levels. Participants take the drug by mouth and provide blood samples to measure drug concentrations. The study does not offer any treatment benefit, as it is designed purely to gather information for future research.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Acpru /Id# 266649
Grayslake, Illinois, 60030, United States
Conditions
Explore the condition pages connected to this study.